Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Treatment with Exenatide versus Glimepiride in Patients with Type 2 Diabetes Pretreated with Metformin
2005-005448-21Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2006
- Modality
- Peptides, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in type 2 diabetes mellitus (T2DM) comparing Exenatide + metformin with Glimepiride + metformin (2 arms). Primary endpoint: Time to treatment failure (TTF). Started May 2006; status: completed.
02
Drugs
exenatideglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-005448-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005448-21.